×
ADVERTISEMENT

Covid-19

Remdesivir Criteria Save on Costs Without Affecting Outcomes

A systemwide shift to more restrictive remdesivir eligibility criteria led to a substantial reduction in ...

DECEMBER 11, 2025

Remdesivir Tied to Lower Mortality in COVID-19 Patients With Liver or Kidney Disease

New data show positive benefits of early treatment with remdesivir in patients with hepatic or renal disease.

OCTOBER 23, 2025

ACIP Narrowly Rejects Prescription Requirement for COVID-19 Vaccines After Day of Heated Debate

The ACIP has voted down a controversial proposal that would have required patients to obtain a prescription before ...

SEPTEMBER 19, 2025

States Consider Their Own Vaccine Guidelines Outside ACIP Recs

States Consider Their Own Vaccine Guidelines Outside ACIP Recs

SEPTEMBER 4, 2025

CVS Will Not Offer COVID-19 Vaccine in 16 States Until ACIP Meets

The pharmacy chain CVS will not offer this season’s COVID-19 shots in states where pharmacists can only ...

AUGUST 29, 2025

FDA Rescinds EUA but Approves Updated 2025-2026 COVID Vaccines

The FDA approved the updated COVID vaccines, but limited who could receive them.

AUGUST 27, 2025

COVID Cases Increasing Across Most of the Country

As of July 29, COVID-19 cases are increasing in at least 40 states. No state is reporting declining cases.

AUGUST 12, 2025

Remdesivir + Corticosteroids Boost Survival in COVID-19 Patients With COPD

Early initiation of remdesivir (Veklury, Gilead Sciences) and corticosteroids in patients with COPD and COVID-19 ...

AUGUST 8, 2025

CMS Updates COVID-19 Vaccination Reporting Requirements

Two COVID-19 vaccination reporting requirements have been removed by the CMS regarding Medicare payment ...

AUGUST 7, 2025

NCCN Guidelines Recommend mAbs for COVID-19 PrEP in People With Cancer

NCCN Guidelines for the Prevention and Treatment of Cancer-Related Infections advise clinicians recommend mAbs to ...

AUGUST 4, 2025

Long Half-Life Seen With Novel mAb for COVID-19

The half life of the novel mAb candidate, VYD2311, may be six months or more. 

JULY 8, 2025

America Still Seeing Many Hospitalizations, Deaths from SARS-CoV-2

The CDC estimates from Oct. 1, 2024 through June 7, 2025, COVID-19 caused an estimated 9.8 million to 16.1 million ...

JULY 2, 2025

Load more